Flavia Kiweewa-Matovu
Kampala, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
Journal: The New England journal of medicine
Published: July 24, 2024
Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
Journal: BMC infectious diseases
Published: June 24, 2020
Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
Journal: AIDS and behavior
Published: November 01, 2019
Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial.
Journal: AJOB empirical bioethics
Published: April 20, 2019
Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 30, 2017
Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: July 27, 2017
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
Journal: The New England journal of medicine
Published: February 23, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026